News and Features Archive

Research

The next step in cancer research

For decades, Nishimura has studied how the immune system targets cancers. More

Research

Loyola Enrolling Brain Tumor Patients in Clinical Trial of a New Radiation Therapy

Loyola Medicine is the only center in Illinois participating in the international multicenter study. More

Research

Kathy Bobay, PhD, RN, NEA-BC, co-author of JAMA study on assessing patient readiness for hospital discharge to reduce readmissions

Reducing readmissions and emergency department visits is a national priority that has led to numerous initiatives to improve the health care experience, patient outcomes and cost of health services. More

Research

LUMC to offer fellowship in Liver and Kidney Transplant Surgery

The American Society of Transplant Surgeons (ASTS) has accredited Loyola Medicine to offer a prestigious two-year fellowship in liver and kidney transplant surgery. More

Research

Leukemia study represents "paradigm change" in treatment of chronic lymphocytic leukemia

A landmark study co-authored by a Loyola Medicine oncologist has found that a newer targeted drug is significantly more effective than standard therapy for treating elderly patients with chronic lymphocytic leukemia (CLL). More

Research

Holly Kramer, PhD, part of study on link between soda and higher kidney disease risk

People who drink lots of sugar-sweetened soda and fruit juices may be more likely to develop chronic kidney disease than those who don’t. More

Research

Apply for NIH Career Development (K) Awards

Since the programs began, the ITM has awarded more than $6.8 million to more than 50 junior investigators at multiple ITM institutions. More

Research

"Loyola study shows black breast cancer patients have worse outcomes than whites, even with similar treatments"

Dr. Albain presented findings of the international study at the San Antonio Breast Cancer Symposium. More

Research

Dept of Radiology study on assessing thyroid imaging reporting and data system for pediatric thyroid nodule malignancy risk

ACR TI-RADS discriminates well between malignant and benign nodules in a pediatric population, particularly at TI-RADS category 5. More

Research

Role of human Hv1 channels in sperm capacitation and white blood cell respiratory burst established by a designed peptide inhibitor (Goldstein lab)

The method should prove amenable to designer toxin identification for other voltage-gated channels. More

Research

Apply for NIH Career Development (K) Awards

Since the programs began, the ITM has awarded more than $6.8 million to more than 50 junior investigators at multiple ITM institutions More

Research

Hepatitis C treatment can be shortened in 50 percent of patients, study finds

Hepatitis C drugs cure more than 90 percent of patients, but can cost more than $50,000 per patient. More